These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6298529)

  • 1. Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys.
    Katz JL; Woods JH; Winger GD; Jacobson AE
    Life Sci; 1982 Nov 15-22; 31(20-21):2375-8. PubMed ID: 6298529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.
    Tang AH; Collins RJ
    Psychopharmacology (Berl); 1985; 85(3):309-14. PubMed ID: 3923516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.
    Woods JH; Young AM; Herling S
    Fed Proc; 1982 Feb; 41(2):221-7. PubMed ID: 7037459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa receptor mediated opioid dependence in rhesus monkeys.
    Gmerek DE; Woods JH
    Life Sci; 1986 Sep; 39(11):987-92. PubMed ID: 3018406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
    Craft RM; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):386-93. PubMed ID: 2542528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of etorphine in Rhesus monkeys.
    Herling S; Woods JH
    Psychopharmacology (Berl); 1981; 72(3):265-7. PubMed ID: 6784144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
    Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
    Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
    Gmerek DE; Dykstra LA; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties.
    May EL; Aceto MD; Bowman ER; Bentley C; Martin BR; Harris LS; Medzihradsky F; Mattson MV; Jacobson AE
    J Med Chem; 1994 Sep; 37(20):3408-18. PubMed ID: 7932569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcotic discrimination in pigeons: antagonism by naltrexone.
    Herling S; Valentino RJ; Solomon RE; Woods JH
    Eur J Pharmacol; 1984 Oct; 105(1-2):137-42. PubMed ID: 6386494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
    Li JX; Becker GL; Traynor JR; Gong ZH; France CP
    J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
    France CP; Medzihradsky F; Woods JH
    J Pharmacol Exp Ther; 1994 Jan; 268(1):47-58. PubMed ID: 8301589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):334-42. PubMed ID: 1309877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.